Healthcare & Medical Devices Global On demand · 24-48h

Global Near Infrared Imaging Market Strategic Research Report

Global Near Infrared Imaging Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Near Infrared Imaging Market
$2.35B2025
3.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Near-infrared Fluorescence Imaging, Diffuse Optical Imaging, Endogenous Reflectance Imaging

By Application: Vascular and Tissue Perfusion Imaging, Tumor Localization and Image-guided Surgery, Lymphatic, Biliary and Anatomical Structure Visualization, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Stryker Corporation, Olympus Corporation, KARL STORZ SE & Co. KG, Hamamatsu Photonics K.K., Shimadzu Corporation, Leica Microsystems GmbH, Carl Zeiss Meditec AG, Getinge AB, Bruker Corporation, Revvity, Inc., LI-COR Biosciences, Inc., OnLume Inc., Mizuho Medical Co., Ltd., NIREC Corporation, Toa Optics Co., Ltd., NeoScience Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen OptoMedic Technologies Inc., Beijing Digital Precision Medicine Technology Co., Ltd., Nanjing Nuoyuan Medical Devices Co., Ltd., Zhuhai Dipu Medical Technology Co., Ltd., Wuhan Zoncare Bio-Medical Electronics Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 152 pages
Market size 2025
$2.35B
Billion USD
Forecast CAGR
3.8%
2025-2032
Forecast 2032
$3.1B
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Near Infrared Imaging market size is predicted to grow from US$ 2,346 million in 2025 to US$ 3,052 million in 2032; it is expected to grow at a CAGR of 3.8% from 2026 to 2032.

In 2025, global Near-Infrared Imaging equipment production reached approximately 30,000 units, with an average global market price of around USD 76,000 per unit.

The gross profit margin of major companies was approximately 42%–65%.

Global production capacity was approximately 40,000 units in 2025.

Near-Infrared Imaging uses light within the near-infrared spectrum to visualize tissue perfusion, blood vessels, tumors, lymphatic structures, or other biological features. Systems commonly combine cameras, illumination sources, optical filters, image-processing software, and optional fluorescent contrast agents. The scope excludes standalone infrared thermography, short-wave infrared industrial cameras, conventional endoscopes, unrelated spectroscopy equipment, contrast agents sold separately, and imaging services.

The industrial chain includes upstream sensors, optical filters, lenses, light sources, lasers, control electronics, and imaging software. Midstream covers optical design, camera integration, software development, calibration, assembly, testing, and regulatory approval. Downstream applications include hospitals, surgical centers, diagnostic imaging, cancer surgery, vascular procedures, plastic surgery, and preclinical research.

Near-Infrared Imaging uses light in the near-infrared wavelength range to visualize tissue structures, blood flow, oxygenation, fluorescent contrast agents, material composition, or other characteristics that are difficult to observe with visible light. Systems generally combine near-infrared light sources, detectors, optical components, image-processing software, and display units. Applications include fluorescence-guided surgery, vascular and tissue-perfusion assessment, cancer detection, ophthalmology, brain-function monitoring, pharmaceutical research, food inspection, and industrial analysis. The market is developing toward higher sensitivity, deeper imaging, real-time processing, miniaturized and portable equipment, multispectral imaging, and integration with endoscopy, surgical robots, and artificial intelligence. Growth is driven by increasing minimally invasive surgery, demand for real-time intraoperative guidance, rising chronic disease prevalence, and wider use of nonionizing diagnostic technologies. However, limited penetration depth, interference from tissue scattering, contrast-agent approval requirements, high equipment costs, and the need for standardized clinical evidence remain important market constraints.

This report presents a comprehensive overview of the global Near Infrared Imaging market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Near-infrared Fluorescence Imaging
  • Diffuse Optical Imaging
  • Endogenous Reflectance Imaging

Segment by System Configuration

  • Handheld Imaging Systems
  • Endoscopic and Laparoscopic Imaging Systems
  • Fixed Surgical and Diagnostic Imaging Systems

Segment by Operating Wavelength

  • NIR-I(700–1,000 nm)
  • NIR-IIa(>1,000–1,350 nm)
  • NIR-IIb(>1,350–1,700 nm)

Segment by Application

  • Vascular and Tissue Perfusion Imaging
  • Tumor Localization and Image-guided Surgery
  • Lymphatic, Biliary and Anatomical Structure Visualization
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Near Infrared Imaging market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Vascular and Tissue Perfusion Imaging, Tumor Localization and Image-guided Surgery, Lymphatic, Biliary and Anatomical Structure Visualization evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Near Infrared Imaging Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.35B
2025
Forecast
$3.1B
2032
CAGR
3.8%
2025–2032
Regiones
5
global
Key companies
Stryker CorporationOlympus CorporationKARL STORZ SE & Co. KGHamamatsu Photonics K.K.Shimadzu CorporationLeica Microsystems GmbHCarl Zeiss Meditec AGGetinge AB
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Near-infrared Fluorescence ImagingDiffuse Optical ImagingEndogenous Reflectance Imaging
By Application
Vascular and Tissue Perfusion ImagingTumor Localization and Image-guided SurgeryLymphaticBiliary and Anatomical Structure VisualizationOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Near-infrared Fluorescence Imaging
  • 3.1.3 Diffuse Optical Imaging
  • 3.1.4 Endogenous Reflectance Imaging
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Vascular and Tissue Perfusion Imaging
  • 4.1.3 Tumor Localization and Image-guided Surgery
  • 4.1.4 Lymphatic, Biliary and Anatomical Structure Visualization
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Stryker Corporation
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Olympus Corporation
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 KARL STORZ SE & Co. KG
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Hamamatsu Photonics K.K.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Shimadzu Corporation
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Leica Microsystems GmbH
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Carl Zeiss Meditec AG
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Getinge AB
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Bruker Corporation
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Revvity, Inc.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 LI-COR Biosciences, Inc.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 OnLume Inc.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Mizuho Medical Co., Ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 NIREC Corporation
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Toa Optics Co., Ltd.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 NeoScience Co., Ltd.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Shenzhen OptoMedic Technologies Inc.
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Beijing Digital Precision Medicine Technology Co., Ltd.
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Nanjing Nuoyuan Medical Devices Co., Ltd.
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Zhuhai Dipu Medical Technology Co., Ltd.
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Wuhan Zoncare Bio-Medical Electronics Co., Ltd.
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Near Infrared Imaging market?
The global Near Infrared Imaging market is estimated at US$ 2.35 billion in 2025 (base year) and is projected to reach US$ 3.05 billion by 2032.
What is the forecast CAGR for the Near Infrared Imaging market?
The market is expected to grow at a CAGR of 3.8% from 2026 to 2032, expanding from US$ 2.35 billion in 2025 to US$ 3.05 billion in 2032, roughly 1.3 times its base-year value.
What is Near Infrared Imaging?
In 2025, global Near-Infrared Imaging equipment production reached approximately 30,000 units, with an average global market price of around USD 76,000 per unit.
What are the main segments of the Near Infrared Imaging market by type?
By type, the market is segmented into Near-infrared Fluorescence Imaging, Diffuse Optical Imaging and Endogenous Reflectance Imaging.
Which applications drive demand in the Near Infrared Imaging market?
Key applications covered include Vascular and Tissue Perfusion Imaging, Tumor Localization and Image-guided Surgery, Lymphatic, Biliary and Anatomical Structure Visualization and Other.
Who are the key players in the Near Infrared Imaging market?
Key players profiled include Stryker Corporation, Olympus Corporation, KARL STORZ SE & Co. KG, Hamamatsu Photonics K.K., Shimadzu Corporation, Leica Microsystems GmbH, Carl Zeiss Meditec AG and Getinge AB, among 22 companies covered in total.
Which regions and countries are covered for Near Infrared Imaging?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Near Infrared Imaging market?
Growth is driven by increasing minimally invasive surgery, demand for real-time intraoperative guidance, rising chronic disease prevalence, and wider use of nonionizing diagnostic technologies.
What challenges does the Near Infrared Imaging market face?
However, limited penetration depth, interference from tissue scattering, contrast-agent approval requirements, high equipment costs, and the need for standardized clinical evidence remain important market constraints.
Who should buy the Near Infrared Imaging market report?
The report is intended for manufacturers and solution providers, distributors and end users in Vascular and Tissue Perfusion Imaging, Tumor Localization and Image-guided Surgery and Lymphatic, Biliary and Anatomical Structure Visualization, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Near Infrared Imaging market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.